Publikationen in Zusammenarbeit mit Forschern von Pfizer (United States) (7)

2025

  1. Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata

    Dermatology and Therapy, Vol. 15, Núm. 6, pp. 1543-1553

  2. Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles

    Advances in Therapy, Vol. 42, Núm. 9, pp. 4556-4570

  3. Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata

    Dermatology and Therapy

2024

  1. Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe

    Dermatology and Therapy, Vol. 14, Núm. 12, pp. 3243-3258

  2. Correction to: Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe (Dermatology and Therapy, (2024), 10.1007/s13555-024-01280-3)

    Dermatology and Therapy

  3. Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis

    Dermatology and Therapy, Vol. 14, Núm. 10, pp. 2759-2769

  4. Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)

    SKIN: Journal of Cutaneous Medicine, Vol. 8, Núm. 2, pp. S395